Skip to main content

BROWN ADVISORY INC

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1345929 BALTIMORE, MD

Position in AMLX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$277,027
+$36,273 QoQ
Shares Held
19,930
0.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

BROWN ADVISORY INC holds $557,338,297 across 8 Drug Manufacturers - Specialty & Generic names. AMLX ranks #7 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 AMLX
Amylyx Pharmaceuticals, Inc.
This page
19,930 $277,027

All Filings in AMLX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $277,027 19,930
2025-12-31 $240,754 19,930
2025-09-30 $270,848 19,930
2025-06-30 $127,751 19,930
2025-03-31 $70,552 19,930
2024-12-31 $75,335 19,930
2024-09-30 $64,638 19,950
2024-06-30 $37,925 19,961
2024-03-31 $56,689 19,961
2023-12-31 $198,145 13,461
2023-09-30 $246,470 13,461
2023-06-30 $290,353 13,461
2023-03-31 $541,645 18,461
2022-12-31 $1,235,644 33,441
2022-09-30 $1,222,864 43,441